Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED)

Organon

Status and phase: Completed; Phase 4

Conditions: Lipid Metabolism Disorder

Treatments: Drug: ezetimibe

Study type: Interventional

Funder types: Industry

Identifiers

NCT00651963

0653-141

2008_007

MK0653-141

Details and patient eligibility

About

Gather additional efficacy and safety (pharmacovigilance) information in the usual daily care in patients with Dyslipidemia on ezetimibe under real conditions in Colombia associated with statins.

Enrollment: 80 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• > 18 years old
• Lipid Metabolic Disorder as Per ATP III who have not reached the goals and who are on statins for at least 4 weeks Or those who require LDL reductions Over 50% to reach the ATP III goals or who need statins in accordance their risk score

Exclusion criteria

• Pregnancy, Breast Feeding
• Moderate/Sever Liver Disease: Child Score > Or = To 7
• Fibrates Terminal Disease
• Contraindications To Receive ezetimibe
• Contraindications To Receive Statins
• Mental Disability
• Hypersensitivity To ezetimibe
• On another Clinical Research Trial

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)